Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Remde

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paragangliomaAlessa Fischer, Hanna Remde, Christina Pamporaki, et al.
European Journal of Endocrinology|June 1, 2023
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort studyHanna Remde, Laura Schmidt-Pennington, Miriam Reuter, et al.
Frontiers in Endocrinology|April 10, 2024
Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertensionRobin Knuchel, Zoran Erlic, Sven Gruber, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paragangliomaMarta Laganà, Mouhammed Amir Habra, Hanna Remde, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2022
Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose PheochromocytomaGeorg Pommer, Christina Pamporaki, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic ResponsesAlessa Fischer, Simon Kloos, Umberto Maccio, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort studyLiang Zhang, Gautier Tisserand, Yanting Shen, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paragangliomaAlessa Fischer, Hanna Remde, Christina Pamporaki, et al.
European Journal of Endocrinology|June 1, 2023
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort studyHanna Remde, Laura Schmidt-Pennington, Miriam Reuter, et al.
Frontiers in Endocrinology|April 10, 2024
Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertensionRobin Knuchel, Zoran Erlic, Sven Gruber, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paragangliomaMarta Laganà, Mouhammed Amir Habra, Hanna Remde, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2022
Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose PheochromocytomaGeorg Pommer, Christina Pamporaki, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic ResponsesAlessa Fischer, Simon Kloos, Umberto Maccio, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort studyLiang Zhang, Gautier Tisserand, Yanting Shen, et al.
Pageof 5